Skip to content

Clinical trials

Phase 1 Intellectual Disability trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Phase: Phase 1 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20151
20161
20221
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Enrolling by invitation1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University2
Connecta Therapeutics, S.L.1
Hsiang-Yuan Lin1
National Human Genome Research Institute (NHGRI)1
Neurogen Brain and Spine Institute1
Queen's University, Belfast1
University Hospitals Cleveland Medical Center1
University of California, Davis1
Vanderbilt University Medical Center1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability12
Developmental Disabilities4
Fragile X Syndrome4
Down Syndrome3
Rare Diseases2
Alzheimer Disease1
Attention Deficit Disorder with Hyperactivity1
Autism Spectrum Disorder1
Autistic Disorder1
Catatonia1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.